Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 570,045
  • Shares Outstanding, K 10,687
  • Annual Sales, $ 0 K
  • Annual Income, $ -44,600 K
  • 60-Month Beta 2.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.52
Trade CRBP with:

Options Overview Details

View History
  • Implied Volatility 88.54% ( -2.18%)
  • Historical Volatility 74.51%
  • IV Percentile 18%
  • IV Rank 0.00%
  • IV High 161.86% on 03/06/24
  • IV Low 88.54% on 07/11/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 20
  • Volume Avg (30-Day) 112
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 1,549
  • Open Int (30-Day) 1,953

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.24
  • Number of Estimates 3
  • High Estimate -0.92
  • Low Estimate -1.71
  • Prior Year -2.05
  • Growth Rate Est. (year over year) +39.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.61 +31.35%
on 06/18/24
55.41 -3.74%
on 06/12/24
+3.03 (+6.02%)
since 06/11/24
3-Month
32.03 +66.54%
on 04/25/24
55.41 -3.74%
on 06/12/24
+13.34 (+33.35%)
since 04/11/24
52-Week
3.03 +1,658.42%
on 11/13/23
55.41 -3.74%
on 06/12/24
+45.44 (+575.19%)
since 07/11/23

Most Recent Stories

More News
Up Over 700% YTD, Here's How Much Higher Analysts Think This Biotech Stock Can Rise

As the biotech industry rebounds from recent challenges, a favorable regulatory environment and groundbreaking scientific advancements are creating investment opportunities, particularly in companies with...

CRBP : 53.34 (+3.59%)
Stocks Climb on Lower Bond Yields and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. US stocks this morning...

$SPX : 5,584.54 (-0.88%)
SPY : 556.48 (-0.86%)
$DOWI : 39,753.75 (+0.08%)
DIA : 397.63 (+0.09%)
$IUXX : 20,211.36 (-2.24%)
QQQ : 491.93 (-2.19%)
ZNU24 : 111-000 (-0.14%)
INCY : 62.29 (+2.57%)
AAPL : 227.57 (-2.32%)
WYNN : 84.61 (+0.83%)
LVS : 42.32 (+2.15%)
MGM : 45.84 (+4.40%)
Corbus Pharmaceuticals: Q1 Earnings Snapshot

Corbus Pharmaceuticals: Q1 Earnings Snapshot

CRBP : 53.34 (+3.59%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 53.34 (+3.59%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 0.6001 (+7.28%)
CARA : 0.3660 (+27.97%)
CRBP : 53.34 (+3.59%)
HRMY : 33.32 (-0.60%)
JAZZ : 106.04 (+3.73%)
Corbus Pharmaceuticals: Q3 Earnings Snapshot

Corbus Pharmaceuticals: Q3 Earnings Snapshot

CRBP : 53.34 (+3.59%)
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an...

CRBP : 53.34 (+3.59%)
Corbus Pharmaceuticals: Q2 Earnings Snapshot

Corbus Pharmaceuticals: Q2 Earnings Snapshot

CRBP : 53.34 (+3.59%)
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate...

CRBP : 53.34 (+3.59%)
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval...

CRBP : 53.34 (+3.59%)

Business Summary

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic...

See More

Key Turning Points

3rd Resistance Point 56.95
2nd Resistance Point 55.65
1st Resistance Point 54.50
Last Price 53.34
1st Support Level 52.05
2nd Support Level 50.75
3rd Support Level 49.60

See More

52-Week High 55.41
Last Price 53.34
Fibonacci 61.8% 35.40
Fibonacci 50% 29.22
Fibonacci 38.2% 23.04
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar